Amsterdam-based Molecular Quantum Solutions (MQS) has raised €600k in a pre-seed funding round led by Scale Capital, with participation from Rockstart and Stokbro Invest. MQS plans to use the funds to convert their tool stack into a software-as-a-service solution for the pharmaceutical and chemical industries. The company’s tools, developed by a team of quantum physicists, chemical engineers, and developers, utilise supercomputers and quantum computing technology to accelerate research and development in these sectors. The technology allows for the rapid calculation of material and chemical properties, potentially reducing the need for costly laboratory experiments.
Molecular Quantum Solutions Secures €600k Pre-seed Funding
Molecular Quantum Solutions, a tech company specialising in quantum computing, has raised €600k in a pre-seed funding round. The round was led by Scale Capital, with participation from Rockstart and Stokbro Invest. The funds will be used to convert the company’s tool stack into a Software as a Service (SaaS) solution for the pharmaceutical and chemical industries.
Molecular Quantum Solutions has a diverse team of quantum physicists, chemical engineers, backend and full-stack developers, and business developers. They have developed advanced computational tools to accelerate research and development efforts in the pharmaceutical, biotech, and chemical sectors. These tools utilise supercomputers and quantum computing technology to rapidly and efficiently calculate material and chemical properties.
The pharmaceutical and biopharmaceutical industries typically invest between approximately 20 and 60 billion USD in drug formulation and manufacturing upscaling phases. With the tools developed by Molecular Quantum Solutions, users can now screen and evaluate new materials for applications such as batteries, green solvents, pharmaceutical drugs, and biodegradable plastics without the need for expensive laboratory experiments.
Quantum Computing in the Pharmaceutical and Chemical Industries
Over the past three years, Molecular Quantum Solutions has built a robust infrastructure to run computationally demanding quantum chemistry calculations in the cloud. They have also developed novel quantum computing methods which are being integrated into their classical calculation pipeline. The company has several collaborations ongoing with quantum computing research institutions and companies.
The CEO/CTO of Molecular Quantum Solutions, Mark Nicholas Jones, commented on the funding round, stating that the company is now set to push into a worldwide market with their cloud products stack. The company’s quantum chemistry simulation platform is expected to disrupt the drug formulation space.
Investment in Molecular Quantum Solutions
“We are thrilled to partner with Mark and the team at MQS and help them get to the next stage. We have been very impressed with their product and commercial achievements so far, and sincerely believe that their quantum chemistry simulation platform will disrupt the drug formulation space. We think the company stands out from the competition and has a clear value proposition for accelerating the pharma R&D pipeline. We are excited to start the work!”
Joachim Schelde, Investment Associate, Scale Capital
Investment Associate at Scale Capital, Joachim Schelde, expressed excitement about partnering with Molecular Quantum Solutions. He praised the company’s product and commercial achievements and expressed belief in the company’s potential to accelerate the pharma R&D pipeline.
Michael Bjørnlund, Managing Partner at Rockstart Emerging Tech, also expressed enthusiasm about investing in Molecular Quantum Solutions. He highlighted the company’s commitment to building complex quantum chemistry solutions in the space of supercomputing and quantum computing.
Molecular Quantum Solutions provides a software platform for calculating thermodynamic properties of molecules. The company’s applications are primarily in the pharmaceutical and chemical industries. The startup is based in Copenhagen, Denmark.
Scale Capital is a venture capital firm that led the recent funding round for Molecular Quantum Solutions. The firm is known for its investments in early-stage tech companies.
“Over the last three years, we have built a solid infrastructure to run computationally demanding quantum chemistry calculations in the cloud and solve industrial relevant use cases. Further, we have developed novel quantum computing methods which we are integrating into our classical calculation pipeline. We have several collaborations ongoing with quantum computing research institutions and companies. We are now set to push into a worldwide market with our cloud products stack.” – Mark Nicholas Jones, CEO/CTO, Molecular Quantum Solutions
“Increasing computing power will play a pivotal role in tackling global issues and shortcutting its time to market can significantly contribute to worldwide problem-solving. We invested in Molecular Quantum Solutions (MQS) to streamline computing power and drive change in Industry 4.0 & advanced analytics development. The MQS team works relentlessly to build highly complex quantum chemistry solutions in the space of supercomputing and quantum computing and we’re excited to have joined their journey early on.”
Michael Bjørnlund, Managing Partner, Rockstart Emerging Tech
Summary
Molecular Quantum Solutions, a tech company specialising in quantum computing, has raised €600k in a pre-seed funding round to develop a Software as a Service (SaaS) solution for the pharmaceutical and chemical industries. The company’s advanced computational tools, which utilise supercomputers and quantum computing technology, aim to accelerate research and development efforts by efficiently calculating material and chemical properties, potentially disrupting the drug formulation space.
- Molecular Quantum Solutions (MQS), a Rockstart Emerging Tech portfolio company, has raised €600k in a pre-seed funding round. The round was led by Scale Capital, with participation from Rockstart and Stokbro Invest.
- MQS plans to use the funding to convert their tool stack into a Software as a Service (SaaS) solution for the pharmaceutical and chemical industries.
- The company’s team of quantum physicists, chemical engineers, developers, and business developers have developed advanced computational tools that leverage supercomputers and quantum computing technology. These tools can rapidly calculate material and chemical properties, accelerating R&D efforts in the pharmaceutical, biotech, and chemical sectors.
- MQS’s tools allow users to screen and evaluate new materials for applications such as batteries, green solvents, pharmaceutical drugs, and biodegradable plastics without the need for expensive laboratory experiments.
- Mark Nicholas Jones, CEO/CTO of MQS, stated that the company has built a solid infrastructure for running quantum chemistry calculations in the cloud and has developed novel quantum computing methods. They are now ready to enter the worldwide market with their cloud products stack.
- Joachim Schelde, Investment Associate at Scale Capital, and Michael Bjørnlund, Managing Partner at Rockstart Emerging Tech, expressed their excitement and belief in the potential of MQS’s quantum chemistry simulation platform to disrupt the drug formulation space.
Read More